Rac1, a potential target for tumor therapy

J Liang, L Oyang, S Rao, Y Han, X Luo, P Yi… - Frontiers in …, 2021 - frontiersin.org
RAS-related C3 botulinum toxin substrate 1 (Rac. 1) is one of the important members of Rho
GTPases. It is well known that Rac1 is a cytoskeleton regulation protein that regulates cell …

Rac1 as a therapeutic anticancer target: Promises and limitations

C Bailly, J Beignet, G Loirand, V Sauzeau - Biochemical pharmacology, 2022 - Elsevier
Small molecule inhibitors of GTPases are increasingly considered for the treatment of
multiple human pathologies. The GTPase Rac1 (Ras-related C3 botulinum toxin substrate 1) …

Rac1: A regulator of cell migration and a potential target for cancer therapy

N Ma, E Xu, Q Luo, G Song - Molecules, 2023 - mdpi.com
Cell migration is crucial for physiological and pathological processes such as
morphogenesis, wound repair, immune response and cancer invasion/metastasis. There are …

Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome

R Leng, G Liao, H Wang, J Kuang, L Tang - Medical oncology, 2015 - Springer
Ras-related C3 botulinum toxin substrate 1 (rac1) has been implicated in tumor epithelial–
mesenchymal transition (EMT); however, limited information is available regarding the role …

RAC1 takes the lead in solid tumors

P De, JC Aske, N Dey - Cells, 2019 - mdpi.com
Three GTPases, RAC, RHO, and Cdc42, play essential roles in coordinating many cellular
functions during embryonic development, both in healthy cells and in disease conditions like …

RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis

HK Bid, RD Roberts, PK Manchanda… - Molecular cancer …, 2013 - AACR
Angiogenesis and metastasis are well recognized as processes fundamental to the
development of malignancy. Both processes involve the coordination of multiple cellular and …

Impact of point mutation P29S in RAC1 on tumorigenesis

V Rajendran, C Gopalakrishnan, R Purohit - Tumor Biology, 2016 - Springer
Abstract A point mutation (P29S) in the RAS-related C3 botulinum toxin substrate 1 (RAC1)
was considered to be a trigger for melanoma, a form of skin cancer with highest mortality …

RAC1B: A Rho GTPase with versatile functions in malignant transformation and tumor progression

C Melzer, R Hass, H Lehnert, H Ungefroren - Cells, 2019 - mdpi.com
RAC1B is an alternatively spliced isoform of the monomeric GTPase RAC1. It differs from
RAC1 by a 19 amino acid in frame insertion, termed exon 3b, resulting in an accelerated …

Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines

C Gest, U Joimel, L Huang, LL Pritchard, A Petit… - BMC cancer, 2013 - Springer
Abstract Background Rho GTPases are involved in cellular functions relevant to cancer. The
roles of RhoA and Rac1 have already been established. However, the role of Rac3 in …

A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells

C Espina, MV Céspedes, MA García-Cabezas… - The American journal of …, 2008 - Elsevier
Colorectal adenocarcinoma is the second cause of cancer mortality in developed countries.
Rac1 is a member of the family of Rho GTPases that regulates many intracellular signaling …